478 results on '"Nelson, William G."'
Search Results
2. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
3. Genomic Characterization of Prostatic Basal Cell Carcinoma
4. Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer
5. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts
6. Genomic and phenotypic heterogeneity in prostate cancer
7. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial
8. Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
9. If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease
10. Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
11. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors
12. Health inequity drives disease biology to create disparities in prostate cancer outcomes
13. Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
14. Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations
15. Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
16. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward
17. Mouse Embryonic Stem Cells Carrying One or Two Defective Msh2 Alleles Respond Abnormally to Oxidative Stress Inflicted by Low-Level Radiation
18. Modeling of PCB Concentrations in Water and Biota (Mytilus edulis) in New Bedford Harbor, Massachusetts
19. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
20. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations
21. Simultaneous quantitative determination of 5-aza-2′-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors
22. Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
23. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2
24. The inflammatory microenvironment and microbiome in prostate cancer development
25. The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation
26. Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men
27. Cost implications of PSA screening differ by age
28. Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males
29. Insight into infection‐mediated prostate damage: Contrasting patterns of C‐reactive protein and prostate‐specific antigen levels during infection
30. Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial
31. Profiling prostate cancer
32. Body fatness and sex steroid hormone concentrations in US men: results from NHANES III
33. Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk
34. AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination
35. Alterations in Nucleolar Structure and Gene Expression Programs in Prostatic Neoplasia Are Driven by the MYC Oncogene
36. Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids
37. Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection
38. GSTP1 Loss Results in Accumulation of Oxidative DNA Base Damage and Promotes Prostate Cancer Cell Survival Following Exposure to Protracted Oxidative Stress
39. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization
40. Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
41. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer
42. Human Papillomavirus 16 E6 Expression Disrupts the p53-Mediated Cellular Response to DNA Damage
43. Nuclear Events of Apoptosis in Vitro in Cell-Free Mitotic Extracts: A Model System for Analysis of the Active Phase of Apoptosis
44. Immunolocalization of Keratin Polypeptides in Human Epidermis Using Monoclonal Antibodies
45. The 50- and 58-Kdalton Keratin Classes as Molecular Markers for Stratified Squamous Epithelia: Cell Culture Studies
46. The New Bedford Harbor Superfund site long-term monitoring program (1993–2009)
47. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors
48. CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate Cancer
49. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
50. Tracking the clonal origin of lethal prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.